REPRESENTATIVE EXPERIENCE Jeff’s representative experience includes:
Patent Litigation
- Takeda Pharmaceuticals v. Teva Pharmaceuticals (D. Del), representing one of the world’s largest pharmaceutical companies (Teva) in the trial of a Hatch-Waxman case relating to Prevacid® with market at issue $1 billion annually.
- Ethypharm v. Teva Pharmaceuticals (D. Del.), representing Teva in the trial of a Hatch-Waxman case relating to orally disintegrating tablet technology.
- AstraZeneca v. Impax Laboratories (S.D.N.Y.), representing a major Bay Area pharmaceutical company (Impax) in the trial of a Hatch-Waxman case relating to Prilosec®, with market at issue in excess of $1 billion.
- Minerals Technology v. Omya (S.D.N.Y.), representing an international minerals company (MTI) in a series of cases relating to wet-end papermaking technology and also including PRE and Walker Process antitrust claims. The trial focused on novel issues of acid-base chemistry.
- Kleen-Tex, Inc. v. Mountville Mills, Inc. (N.D. Ga.), representing Kleen-Tex, a leading manufacturer of mats and floor covering, asserting a patent directed to novel manufacturing techniques and novel mat designs. After trial, the court found the client’s patents valid and infringed and awarded “exceptional case” attorneys’ fees.
- Equifax, Inc. v. Verid, Inc. (N.D. Ga.), representing Equifax in asserting patents directed to Internet/online authentication technology. The matter settled with a licensing arrangement after Markman.
- In re Gemstar Litigation (N.D. Ga), representing a major international communications/entertainment company (Gemstar/T.V. Gudie), in a series of cases relating to set-top box technologies in which antitrust and patent misuse claims also were involved. The case was reported to be the largest set of patent matters in the country.
- Depomed, Inc. v. Ivax Pharmaceuticals (N.D. Cal.), representing a major pharmaceutical company (Ivax) in a case relating to polymer controlled release delivery systems. The case settled through mediation on the eve of trial.
- University of Georgia Research Foundation v. KB Visions, Inc. (M.D. Ga.), representing UGA in disputes concerning discovery of Restasis® (cyclosporine ophthalmic emulsion) and administration of patents. We obtained summary judgment on all claims, with a market value in excess of $300 million.
- Oklahoma Medical Research Foundation v. Eli Lilly Corp. (W.D. Ok.), representing OMRF in a dispute concerning Xigris® (drotrecogin alfa), the first drug approved for treatment of sepsis in humans. The case settled after Markman trial. The market sales exceed $200 million.
- Emory University v. Glaxo Wellcome, Inc. (N.D. Ga.), representing Emory University in disputes arising from Emory professors’ discovery and development of Emtriva® (emtricitabine), an anti-retroviral agent approved to treat HIV and HBV. The case settled on the eve of trial. Annual sales exceed $1 billion.
- Emory University v. BioChem Pharma, Inc. (N.D. Ga.), asserting Emory patents covering Epivir® (lamivudine), one of the first anti-retroviral agents approved to treat HIV. The case settled after discovery. Annual sales exceed $1 billion.
- FMT Corp. v. Crown Cork & Seal Company (N.D. Ga.), representing Crown Cork in a case involving the design of petalloid Coca-Cola® bottles.
- Teva Pharmaceuticals v. Dr. Reddy’s Laboratories (D.N.J.), representing Teva in asserting patents directed to methods of synthesizing Avapro® (carvedilol). The matter settled after Markman.
- Jamestown LP v. CBS News Corp. (S.D.N.Y.), representing the owner of One Times Square against CBS in the first U.S. litigation concerning digital video technology and rights of publicity.
- Southern Bonded Group v. S.C. Johnson & Sons (N.D. Ga.), representing Johnson Wax in a professional liability and trademark dispute. The jury entered a verdict in client’s favor, including award of costs and attorneys’ fees.
Transnational Arbitration
- Adidas AG v. Miner Elastomer Products Corp. (ICC, Geneva), representing an athletic shoe manufacturer in a patent and inventorship dispute concerning novel midsole design.
- Rauma-Repola OY v. Hymmen GmbH (ZCC, Zürich), representing Rauma, the largest public company in Scandinavia, in a series of disputes over dissolution of a joint venture and ownership of intellectual property. Claims exceeded $100 million.
- Promotoras Unidas Ltda. v. Unit Chemical (ICC, Mexico City; AAA, Los Angeles), representing Promotoras Unidas, a major developer of chemical products and sanitizers, in a series of cases involving ownership of intellectual property. We successfully prosecuted claims; the client was awarded attorneys’ fees.
- Sunds Defibrator OY v. Crown Inc. (LCIA London), representing in the leading manufacturer of panelboard manufacturing equipment, in an inventorship/business divorce dispute.
- Raytheon Engineers & Constructors, Inc. v. Westlake Styrene, Inc. (AAA Houston, Tx.), representing Raytheon in claims arising from the design of styrene manufacturing facility.
- SIPA SpA v. Nissei AG (ICC Geneva), representing SIPA, an Italian packaging manufacturer, in claims over ownership and inventorship of patents covering PET bottles. Our client was awarded attorneys’ fees. The market is valued in excess of $50 million.
PROFESSIONAL HONORS AND AWARDS
- Named among the “Legal Elite” by Georgia Trend magazine (2007)
- Selected for inclusion in Georgia SuperLawyers® (2007–2009)
PROFESSIONAL AND COMMUNITY INVOLVEMENT
- Former Board President and Counsel, Men Stopping Violence
- Former Trustee, Lawyers’ Committee for Civil Rights Under Law
- Guardian ad Litem, Fulton County Superior Court
RECENT PUBLICATIONS AND SPEAKING ENGAGEMENTS
- Author, published works in OTS Journal, the Meso-American Research Reporter, and the American Journal of Botany
- Speaker, PLI’s Patent Litigation 2007 (November 5–6, 2007)
- Instructor, National Institute of Trial Advocacy trial and appellate advocacy programs (2003–present)